
Opinion|Videos|May 22, 2024
Considerations for Maintenance Therapy in the Community Oncology Setting
Key opinion leaders address the importance of coordination between academic hospital providers and community oncologists when transitioning from initiation of bispecific antibodies at a tertiary hospital to maintenance therapy in the community oncology setting.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
3
Billions at Stake: 340B Program Integrity and Sustainability in 2024–2025
4
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
5

















































































































































































































